129 related articles for article (PubMed ID: 36410436)
1. A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling.
Maemoto T; Kitai Y; Takahashi R; Shoji H; Yamada S; Takei S; Ito D; Muromoto R; Kashiwakura JI; Handa H; Hashimoto A; Hashimoto S; Ose T; Oritani K; Matsuda T
J Biol Chem; 2023 Jan; 299(1):102724. PubMed ID: 36410436
[TBL] [Abstract][Full Text] [Related]
2. STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization.
Kitai Y; Iwakami M; Saitoh K; Togi S; Isayama S; Sekine Y; Muromoto R; Kashiwakura JI; Yoshimura A; Oritani K; Matsuda T
J Biol Chem; 2017 Nov; 292(47):19392-19399. PubMed ID: 28986450
[TBL] [Abstract][Full Text] [Related]
3. Potential of targeting signal-transducing adaptor protein-2 in cancer therapeutic applications.
Maemoto T; Sasaki Y; Okuyama F; Kitai Y; Oritani K; Matsuda T
Explor Target Antitumor Ther; 2024; 5(2):251-259. PubMed ID: 38745775
[TBL] [Abstract][Full Text] [Related]
4. STAP-2-Derived Peptide Suppresses TCR-Mediated Signals to Initiate Immune Responses.
Sasaki Y; Saitoh K; Kagohashi K; Ose T; Kawahara S; Kitai Y; Muromoto R; Sekine Y; Ichii M; Yoshimura A; Oritani K; Kashiwakura JI; Matsuda T
J Immunol; 2023 Sep; 211(5):755-766. PubMed ID: 37417746
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.
Hasegawa Y; Takahashi M; Ariki S; Saito A; Uehara Y; Takamiya R; Kuronuma K; Chiba H; Sakuma Y; Takahashi H; Kuroki Y
J Biol Chem; 2017 Nov; 292(45):18565-18576. PubMed ID: 28972165
[TBL] [Abstract][Full Text] [Related]
6. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
7. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
Justman QA; Clinton GM
J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.
Hasegawa Y; Takahashi M; Ariki S; Asakawa D; Tajiri M; Wada Y; Yamaguchi Y; Nishitani C; Takamiya R; Saito A; Uehara Y; Hashimoto J; Kurimura Y; Takahashi H; Kuroki Y
Oncogene; 2015 Feb; 34(7):838-45. PubMed ID: 24608429
[TBL] [Abstract][Full Text] [Related]
9. A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity.
Xie X; Zhou W; Hu Y; Chen Y; Zhang H; Li Y
Cell Death Dis; 2018 Mar; 9(3):379. PubMed ID: 29515106
[TBL] [Abstract][Full Text] [Related]
10. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
Chaib I; Karachaliou N; Pilotto S; Codony Servat J; Cai X; Li X; Drozdowskyj A; Servat CC; Yang J; Hu C; Cardona AF; Vivanco GL; Vergnenegre A; Sanchez JM; Provencio M; de Marinis F; Passaro A; Carcereny E; Reguart N; Campelo CG; Teixido C; Sperduti I; Rodriguez S; Lazzari C; Verlicchi A; de Aguirre I; Queralt C; Wei J; Estrada R; Puig de la Bellacasa R; Ramirez JL; Jacobson K; Ditzel HJ; Santarpia M; Viteri S; Molina MA; Zhou C; Cao P; Ma PC; Bivona TG; Rosell R
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376152
[TBL] [Abstract][Full Text] [Related]
11. Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages.
Sekine Y; Yumioka T; Yamamoto T; Muromoto R; Imoto S; Sugiyma K; Oritani K; Shimoda K; Minoguchi M; Akira S; Yoshimura A; Matsuda T
J Immunol; 2006 Jan; 176(1):380-9. PubMed ID: 16365431
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factor.
Gresham J; Margiotta P; Palad AJ; Somers KD; Blackmore PF; Wright GL; Schellhammer PF; Wasilenko WJ
Int J Cancer; 1998 Sep; 77(6):923-7. PubMed ID: 9714065
[TBL] [Abstract][Full Text] [Related]
13. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
14. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
Xu D; Makkinje A; Kyriakis JM
J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
[TBL] [Abstract][Full Text] [Related]
15. Decreased mitogenic response to epidermal growth factor in human squamous cell carcinoma lines overexpressing epidermal growth factor receptor owing to limiting amounts of the adaptor protein Grb2: rescue by retinoic acid treatment.
Crowe DL; Tsang KJ
Mol Carcinog; 2001 Dec; 32(4):187-94. PubMed ID: 11746830
[TBL] [Abstract][Full Text] [Related]
16. Possible Therapeutic Applications of Targeting STAP Proteins in Cancer.
Matsuda T; Oritani K
Biol Pharm Bull; 2021; 44(12):1810-1818. PubMed ID: 34853263
[TBL] [Abstract][Full Text] [Related]
17. STAP-2 negatively regulates both canonical and noncanonical NF-kappaB activation induced by Epstein-Barr virus-derived latent membrane protein 1.
Ikeda O; Sekine Y; Yasui T; Oritani K; Sugiyma K; Muromoto R; Ohbayashi N; Yoshimura A; Matsuda T
Mol Cell Biol; 2008 Aug; 28(16):5027-42. PubMed ID: 18573890
[TBL] [Abstract][Full Text] [Related]
18. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor.
Rojas M; Yao S; Lin YZ
J Biol Chem; 1996 Nov; 271(44):27456-61. PubMed ID: 8910327
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
20. A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.
Li M; Yang J; Zhang L; Tu S; Zhou X; Tan Z; Zhou W; He Y; Li Y
J Exp Clin Cancer Res; 2019 May; 38(1):211. PubMed ID: 31118055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
